MICHAEL PATRICK MILLER - 01 Feb 2026 Form 3 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
Director
Signature
/s/ Raymond Furey (Attorney-in-Fact)
Issuer symbol
RIGL
Transactions as of
01 Feb 2026
Net transactions value
$0
Form type
3
Filing time
03 Feb 2026, 16:04:59 UTC
Previous filing
12 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MILLER MICHAEL PATRICK Director RIGEL PHARMACEUTICALS, INC., 611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO /s/ Raymond Furey (Attorney-in-Fact) 03 Feb 2026 0001236514

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RIGL Common Stock 187 01 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RIGL Stock Option (right to buy) 01 Feb 2026 Common Stock 625 $16.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 375 shares subject to this option are vested, and the remaining 250 shares subject to this option will vest in substantially equal installments on February 28, March 29, April 29, and May 29, 2026.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney